PGAP2 p.Arg16Trp
c.46C>T · rs773359554 · VCV50505
Computational evidence
| Protein change | ||
| AlphaMissense | 0.3702 | ambiguous |
|---|---|---|
| REVEL | 0.351 | indeterminate |
| SaProt | LLR -12.06 | damaging |
| Splicing | ||
| SpliceAI | <0.2 | all four deltas below 0.2 · C>A here scores Δ0.38 · evaluated, not missing |
| Constraint at this position | ||
| Conservation | phyloP 4.9 | GERP 1.9, phastCons 1 |
| Regional constraint | o/e 0.48 | unconstrained · MANE · 161 bp · p 1.5e-05 · regional, not allelic |
| Overall | ||
| CADD | 31.0 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Finnishnot grpmax-eligible | 0.0406% | 2,462 |
| Remaining individualsnot grpmax-eligible | 0.0048% | 20,825 |
| East Asiangrpmax | 0.00223% | 44,890 |
| European (non-Finnish) | 0.00153% | 65,552 |
| South Asian | 0.0011% | 91,086 |
Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- PGAP2
- Protein
- p.Arg16Trp
- Coding
- c.46C>T
- MANE Select
- NM_014489
- dbSNP
- rs773359554
- Type
- single nucleotide variant
- Location
- chr11:3811305 (GRCh38)
- Gene constraint
- LOEUF 0.871 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 90.00
- Residue 16
- a UniProt-annotated variant site (in hpmrs3)
Disease context
hyperphosphatasia with intellectual disability syndrome 3 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Hyperphosphatasia-intellectual disability syndrome (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Infancy, Neonatal
Similar variants
- PGAP2 p.Arg16Gln Uncertain significance ★ ⚠ same residue
- PGAP2 p.Ala127Val Likely pathogenic ★★ same condition
- PGAP2 p.Arg238Pro Pathogenic/Likely pathogenic ★★ ⚠ same condition
- PGAP2 p.Thr294Met Likely pathogenic ★★ same condition
- PGAP2 c.602-3C>T Uncertain significance ★★ same condition
- PGAP2 p.Asn205Lys Uncertain significance ★★ ⚠ same condition
- PGAP2 p.Ser257Leu Uncertain significance ★★ ⚠ same condition
- PGAP2 c.166-1G>C Likely pathogenic ★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/pgap2-p-arg16trp (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown